COLOMBATTI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 5.338
EU - Europa 4.410
AS - Asia 1.411
SA - Sud America 20
AF - Africa 8
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
Totale 11.200
Nazione #
US - Stati Uniti d'America 5.289
GB - Regno Unito 2.108
CN - Cina 1.077
SE - Svezia 450
IE - Irlanda 342
FI - Finlandia 305
FR - Francia 304
DE - Germania 250
IT - Italia 213
RU - Federazione Russa 209
SG - Singapore 153
UA - Ucraina 113
BE - Belgio 44
TR - Turchia 40
CA - Canada 32
KR - Corea 29
IN - India 21
IR - Iran 21
VN - Vietnam 19
NL - Olanda 18
JP - Giappone 12
BR - Brasile 11
MX - Messico 11
AU - Australia 7
AT - Austria 6
ES - Italia 6
PH - Filippine 6
PT - Portogallo 6
CH - Svizzera 5
AR - Argentina 4
EU - Europa 4
ID - Indonesia 4
LV - Lettonia 4
MA - Marocco 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
AZ - Azerbaigian 3
BD - Bangladesh 3
HK - Hong Kong 3
PA - Panama 3
PL - Polonia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
CM - Camerun 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
HR - Croazia 2
HU - Ungheria 2
JM - Giamaica 2
LU - Lussemburgo 2
SA - Arabia Saudita 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
BS - Bahamas 1
BT - Bhutan 1
BY - Bielorussia 1
CL - Cile 1
DK - Danimarca 1
EG - Egitto 1
IL - Israele 1
IQ - Iraq 1
IS - Islanda 1
JO - Giordania 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
ME - Montenegro 1
MY - Malesia 1
NO - Norvegia 1
RS - Serbia 1
TJ - Tagikistan 1
UY - Uruguay 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 11.200
Città #
Southend 1.866
Jacksonville 1.013
Chandler 875
Woodbridge 723
Ann Arbor 489
Dublin 342
Ashburn 310
Houston 261
Beijing 188
Wilmington 150
Lawrence 132
Princeton 132
Jinan 119
Singapore 117
Nanjing 111
Shenyang 99
New York 83
Verona 83
Hebei 64
Boardman 63
Helsinki 59
Tianjin 55
Seattle 47
Brussels 44
Changsha 43
Sindelfingen 42
Zhengzhou 38
Taizhou 36
Ningbo 34
Cambridge 33
Milan 33
Nanchang 32
Fairfield 31
Haikou 30
Philadelphia 29
Hangzhou 28
Jiaxing 28
Falls Church 27
Norwalk 25
Seoul 25
Taiyuan 24
Los Angeles 23
Fuzhou 22
Guangzhou 21
Auburn Hills 18
Lancaster 18
Lanzhou 15
San Francisco 14
Montréal 12
Redwood City 12
Bologna 11
Amsterdam 9
Detroit 9
Edinburgh 9
Kent 9
Dong Ket 8
San Mateo 8
Dearborn 7
Elora 7
Tappahannock 7
Tehran 7
Ardabil 6
Augusta 6
Dongguan 6
Leawood 6
London 6
Phoenix 6
Tokyo 6
Washington 6
Düsseldorf 5
Padova 5
Rome 5
Bratislava 4
Chicago 4
Innsbruck 4
Kyoto 4
Mumbai 4
Nürnberg 4
San Diego 4
Toronto 4
Baku 3
Fremont 3
Hanoi 3
Kemerovo 3
Kochi 3
Las Vegas 3
Lisbon 3
Naples 3
Ottawa 3
Riga 3
Riva 3
Sacramento 3
San Jose 3
Sejong 3
Shanghai 3
Warsaw 3
Windsor 3
Ypsilanti 3
Andover 2
Bucharest 2
Totale 8.362
Nome #
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 171
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 162
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Associated to a B7-1-Expressing Tumor Cell Vaccine Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer. 158
Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity 143
Ectopic expression of the heterotrimeric G15 protein in pancreatic carcinoma and its potential in cancer signal transduction 133
Carrier protein-monensin conjugates: enhancement of immunotoxin cytotoxicity and potential in tumor treatment 128
Anti PSMA immunotoxins activity against prostate cancer cell lines. 123
Cytoreductive effects of anti-transferrin receptor immunotoxin in a multicellular tumor spheroid model 122
Escape mechanisms of human leukemic cells to long-term immunotoxin treatment in an in vitro experimental model 120
Blocking effect of human serum but not of cerebrospinal fluid on ricin A chain immunotoxin potentiation by monensin or carrier protein-monensin conjugates 119
Sensitivity of human leukemia cells in exponential or stationary growth phase to anti-CD5 immunotoxins. Role of intracellular processing events 116
Disposition of intrathecally administered immunotoxins in rats. A preliminary report 114
Cooperation of Prostate Specific Membrane Antigen with beta 1 integrin promotes the survival of aggressive prostate cancer cells 113
Immunotoxins and other conjugates: preparation and general characteristics. 112
T cell immune function in newborn infants 110
Hybridoma cells containing intracellular anti-ricin antibodies show ricin meets secretory antibody before entering the cytosol 110
Problems and potentials in immunotoxin therapy 109
Anti-tumor effects of toxins targeted to the prostate specific membrane antigen. 107
Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen 105
Heterogeneity and modulation of tumor-associated antigens in human glioblastoma cell lines 105
Anti-PSMA-Immunotoxins: a new therapeutical strategy for selective targeting of toxins to prostate cancer cells. 104
Produzione e validazione preclinica di un anticorpo anti-PSMA per diagnostica ed immunotargeting 103
Mechanisms involved in serum-dependent inactivation of the immunotoxin enhancers monensin and carrier-protein-monensin 101
Human glioma cell lines: tumour associated antigens distribution and sensitivity to antibody-toxin or ligand-toxin conjugates. A preliminary report 101
The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumor cells by activating the MAPK pathways. 101
Sensitivity of human glioma cells to cytotoxic heteroconjugates 100
A fluorescence-based assay for the reductase activity of protein disulfide isomerase. 100
Apical transport and folding of prostate-specific membrane antigen occurs independent of glycan processing. 100
A SERRS/MRI multimodal contrast agent based on naked Au nanoparticles functionalized with a Gd(iii) loaded PEG polymer for tumor imaging and localized hyperthermia 100
Overexpression of N-ras oncogene and epidermal growth factor receptor gene in human glioblastomas 99
Internalization and intracellular fate of anti-CD5 monoclonal antibody and anti-CD5 ricin A-chain immunotoxin in human leukemic T cells 99
Thy 1.2+ leukemia cells eradicated from in vitro leukemia-bone marrow cell mixtures by antibody-toxin conjugates 99
Reductive activation of ricin and ricin-A chain immunotoxins by Protein Disulfide Isomerase and Thioredoxin Reductase system. 99
N-terminal deletion affetcs catalytic activity of saporin toxin. 99
Identification and characterization of a monoclonal antibody recognizing a galactose-binding domain of the toxin ricin 98
Protein Disulfide Isomerase and Thioredoxin Reductase: a ricin disulfide reducing system in the endoplasmic reticulum. 98
Adhesion of immature and mature T cells induces in human thymic epithelial cells (TEC) activation of IL-6 gene trascription factors (NF-kappaB and NF-IL6) and IL-6 gene expression: role of alpha3beta1 and alpha6beta4 integrins. 98
Characterization of a new anti PSCA monoclonal antibody and scFv fragment for diagnosis and immunotherapy of prostate, pancreatic and bladder carcinoma. 98
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 98
Anticorpo monoclonale isolato o suo frammento legante l'antigene specifico di membrana della prostata, suoi coniugati e suoi usi 98
The prostate specific membrane antigen regulates the expression of IL-6 and CCL-5 in prostate tumour cells by activating the MAPK pathways 98
Plasmonic Nanostructures for SERRS Multiplexed Identification of Tumor-Associated Antigens 98
Human immune response to ricin A-chain: identification of T-cell and B-cell epitopes. 97
EpCAM a possible target for immunotoxin treatments of PSMA positive and negative prostate cancer cells 97
A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer 97
The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis 97
Ingegnerizzazione di un vettore per espressione di frammenti anticorpali (scFv) biotinilati in procarioti, purificazione ed analisi funzionale 95
Targeted delivery of photosensitizers: efficacy and selectivity issues revealed by multifunctional ORMOSIL nanovectors in cellular systems 95
Distribution of endocytosed molecules to intracellular acidic environments correlates with immunotoxin activity 93
Production of a biotinylated anti-PSMA single-chain antibody fragment (scFv) for imaging and radioimmunotherapy 92
Anti PSCA Monoclonal Antibody and scFv-Fragment for Immunotherapy of Prostate, Pancreatic and Bladder Carcinoma 92
Lipid interaction of diphtheria toxin and mutants with altered fragment B. 2. Hydrophobic photolabelling and cell intoxication 91
Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase. 91
Investigation of Properties of Anti-Prostate Specific Membrane Antigen-targeted Gold Nanoparticles as Drug Carriers in Tumor Therapy 91
Human MBP-specific T cells regulate IL-6 gene expression in astrocytes through cell-cell contacts and soluble factors 90
Parallel optical read-out of micromechanical pillars applied to prostate specific membrane antigen detection 89
Monoclonal antibodies against ricin: effects on toxin function 89
Selective killing of target cells by antibody-ricin A chain or antibody-gelonin hybrid molecules: comparison of cytotoxic potency and use in immunoselection procedures 89
Fluorescent Assay to Demonstrate the Interaction of Thioredoxin Reductase and Protein Disulfide Isomerase. 89
FLUORESCENT ASSAY TO TEST PROTEIN DISULFIDE ISOMERASE ACTIVITY INDUCED BY THIOREDOXIN REDUCTASE. 89
Prostate-specific membrane antigen associates already in the endoplasmic reticulum with lipid microdomains 89
Constitutive activation of p38 and ERK1/2 MAPKs in epithelial cells of myasthenic thymus leads to IL-6 and RANTES overexpression: effects on survival and migration of peripheral T and B cells. 88
Isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen, conjugates and uses thereof 87
HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection 86
Effect of therapeutic macromolecules in spheroids 86
Potentiation of cytotoxic heteroconjugates by monensin-carrier proteins 86
A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin 85
Anti-prostate specific membrane antigen targeted gold nanoparticles in tumor therapy and diagnosis 85
Top-down synthesis of multifunctional iron oxide nanoparticles for macrophage labelling and manipulation 85
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 85
Self-potentiation of ligand-toxin conjugates containing ricin A chain fused with viral structures 85
Cloned fragment of diphtheria toxin linked to T cell-specific antibody identifies regions of B chain active in cell entry 84
Peptide analogues of a T-cell epitope of ricin toxin A-chain prevent agonist-mediated human T-cell response in vitro. 84
Prostate-specific membrane antigen (PSMA) associates early in the endoplasmic reticulum with lipid microdomains 84
Tumor Targeting with Guided Silica Nanopartilces for Prostate Cancer Therapy 84
Targeting human prostate cancer with (111) In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts. 83
Sensitivity of target cells to immunotoxins: possible role of cell-surface antigens 83
Biodistribution of In-111-labeled D2B IgG, F(ab’)2 and Fab fragments in nude mice bearing human prostate cancer xenografts 83
Generazione di nuovi anticorpi anti prostate stem cell antigen (PSCA) e loro caratterizzazione al fine di un futuro utilizzo nella terapia e nella diagnosi dei carcinomi prostatico, pancreatico e della vescica 82
Chemical conjugation of ΔF508-CFTR corrector deoxyspergualin to transporter human serum albumin enhances its ability to rescue Cl- channel functions. 81
Discriminatory role of detergent-resistant membranes in the dimerization and endocytosis of prostate-specific membrane antigen 81
Human large granular lymphocytes contain an esterase activity usually considered as specific for the myeloid series 80
Identification of Ricin A chain HLA II-restricted epitopes by human T-cell clones. 79
Reductive activation of type 2 ribosome inactivating proteins (RIPs 2) is promoted by transmembrane thioredoxin-related protein (TMX) 78
Lymphocyte phenotypic subsets in umbilical cord blood compared to peripheral blood from related mothers 78
The Proinflammatory Cytokine, IL-6, and its Interference with bFGF Signaling and PSMA in Prostate Cancer Cells. 76
Late generation lentiviral vectors: evaluation of inflammatory potential in human airway epithelial cells. 76
Standardization of in vitro synthesis and detection of HIV-1-specific antibodies 75
IL-6 gene expression in human astrocytes is enhanced after adhesion to MBP-specific T-cells: role of beta1 integrin and IFN-gamma in the induction of NF-kB and IRF-1 binding activity 75
Magneto-Plasmonic Au-Fe alloy nanoparticles designed for multimodal SERS-MRI-CT imaging 75
PSMA-Specific CAR-Engineered T Cells Eradicate Disseminated Prostate Cancer in Preclinical Models 75
The Filamin A-mediated cooperation of Prostate Specific Membrane Antigen (PSMA) with beta1 integrin promotes the survival of aggressive prostate cancer cells. 74
Pharmacokinetics of intrathecal transferrin-ricin A chain immunotoxins 73
Heterogeneous response of individual multicellular tumour spheroids to immunotoxins and ricin toxin 73
Cloning and characterisation of canine prostate-specific membrane antigen 73
Prostate Specific Membrane Antigen (PSMA) associates with Filamin A, beta1 integrin, pp130CAS and pSrc thus regulating the activation of beta1 integrin and the survival of prostate cancer cells. 73
Preliminary results of Soft X-ray Absorption Near Edge Spectroscopy of sulfur in biomolecules. 71
null 70
On the growth of dynamics of multicellular tumor spheroids : a preliminary report 68
Prostate-specific membrane antigen routing to the cell surface implicates an early association step in the endoplasmic reticulum with lipid microdomains. 67
Totale 9.517
Categoria #
all - tutte 33.165
article - articoli 23.676
book - libri 0
conference - conferenze 7.950
curatela - curatele 0
other - altro 0
patent - brevetti 471
selected - selezionate 0
volume - volumi 1.068
Totale 66.330


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.256 0 16 6 138 142 169 139 118 55 146 79 248
2020/20211.306 107 200 83 124 165 155 13 110 91 13 191 54
2021/20221.157 111 308 6 99 39 36 29 78 43 29 110 269
2022/20232.478 175 230 210 402 239 577 89 200 262 12 61 21
2023/2024991 55 93 82 134 111 144 30 71 13 80 124 54
2024/2025262 176 86 0 0 0 0 0 0 0 0 0 0
Totale 11.272